Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin -3 ones for evaluation of antimicrobial and anticancer activity

Farmaco

Volumn 53, Issue 7, 1998, Pages 455-461

  Sanna, Paolo ^a   Carta, Antonio ^a   Loriga, Mario ^a   Zanetti, Stefania ^a   Sechi, Leonardo ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Anticancer activity; Antimicrobial activity; Quinoxalinones

Indexed keywords

2 QUINOXALINECARBOXYLIC ACID; 2(1H) QUINOXALINONE DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032581432     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00044-5     Document Type: Article

References (32)

1. [1] G.W.H. Cheeseman, R.F. Cookson, Condensed Pyrazines, in: A. Weissberger, E.C. Taylor (Eds.), Heterocyclic Compounds, vol. 35, Wiley, New York, 1979, pp. 78-94.
2. [2] T. Honore, S.N. Davies, J. Drejer, E.J. Fletcher, P. Jacobsen, D. Lodge, F.E. Neilsen, Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonist, Science 241 (1988) 701-703.
3. [3] P.D. Leeson, L.L. Iversen, The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential, J. Med. Chem. 37 (1994) 4053-4067.
4. [4] Fujisawa Pharmaceutical Co., Preparation of quinoxaline derivatives as aldose reductase inhibitors and a process for their preparation, Jpn. Kokai Tokkyo Koho JP 63 301 874 (1988) [Chem. Abstr. 111 (1989) 78027u].
5. [4] Fujisawa Pharmaceutical Co., Preparation of quinoxaline derivatives as aldose reductase inhibitors and a process for their preparation, Jpn. Kokai Tokkyo Koho JP 63 301 874 (1988) [Chem. Abstr. 111 (1989) 78027u].
6. [5] C.H. Beherens, B.A. Dusak, B.A. Harrison, M.J. Orwat, 2-[(Quinoxalinyloxy)phenoxy] propanoates and related derivatives as anticancer agents, PCT Int. Appl. WO 94 13 647 (1994) [Chem. Abstr. 121 (1994) 157671j].
7. [5] C.H. Beherens, B.A. Dusak, B.A. Harrison, M.J. Orwat, 2-[(Quinoxalinyloxy)phenoxy] propanoates and related derivatives as anticancer agents, PCT Int. Appl. WO 94 13 647 (1994) [Chem. Abstr. 121 (1994) 157671j].
8. [6] M. Yaso, Y. Suzuki, T. Saito, D. Mochizuki, Preparation of 2-(1-piperazinylaliloxy) quinoxaline derivatives for treatment of serotoninergic disorders, PCT Int. Appl. WO 93 12 792 (1993) [Chem. Abstr. 120 (1994) 8617y].
9. [6] M. Yaso, Y. Suzuki, T. Saito, D. Mochizuki, Preparation of 2-(1-piperazinylaliloxy) quinoxaline derivatives for treatment of serotoninergic disorders, PCT Int. Appl. WO 93 12 792 (1993) [Chem. Abstr. 120 (1994) 8617y].
10. [7] M. Loriga, M. Fiore, P. Sanna, G. Paglietti, Quinoxaline chemistry, Part 4. 2-(R)-Anilinoquinoxalines as non classical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity, Farmaco 50 (1995) 289-301.
11. [8] M. Loriga, M. Fiore, P. Sanna, G. Paglietti, Quinoxaline chemistry, Part 5. 2-(R)-Benzylaminoquinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity, Farmaco 51 (1996) 559-568.
12. [9] M. Loriga, S. Piras, P. Sanna, G. Paglietti, Quinoxaline chemistry, Part 7. 2-[Aminobenzoates]-and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity, Farmaco 52 (1997) 157-166.
13. [10] M. Loriga, A. Nuvole, G. Paglietti, S. Zanetti, G. Fadda, 2-Phenyl-6(7)-R-substituted quinoxalines N-oxides. Synthesis, structure elucidation and antimicrobial activity, Eur. J. Med. Chem. 25 (1990) 527-532.
14. [11] P. Sanna, A. Carta, S. Zanetti, Sintesi e valutazione bioiogica in vitro di carbossi-e carbossietilchinossaline e chinossalinoni variamente sostituiti, Atti II Congr. Congiunto Italiano-Spagnolo di Chimica Farmaceutica, Ferrara, Italy, 30 Aug.-3 Sept. 1995, P11.
15. [12] P. Sanna, A. Carta, M. Loriga, S. Zanetti, I. Duprè, Preparazione e valutazione microbiologica in vitro di nuovi derivati 3,4-diidrochinossalinonici variamente sostituiti, Atti XIII Convegno Nazionale della Divisione di Chimica Farmaceutica, Paestum, Italy, 23-27 Sept. 1996, Italian Chemical Society, Rome, p. 176.
16. [13] R.F. Abdulla, K.H. Fuhr, Azeto[1,2-a]quinoxaline-1,3-diones, a new class of bridgehead nitrogen β-lactams, J. Heterocycl. Chem. 13 (1976) 427-432.
17. [14] Y. Yamada, K. Kishi, H. Yasuda, The reaction of tetraethoxycarbonylethylene with aromatic 1,2-diamines, Utsunomiya Daigaku Kyoikugakubu Kiyo Dai-2-bu 37 (1987) 49-55 [Chem. Abstr. 107 (1987) 236662w].
18. [14] Y. Yamada, K. Kishi, H. Yasuda, The reaction of tetraethoxycarbonylethylene with aromatic 1,2-diamines, Utsunomiya Daigaku Kyoikugakubu Kiyo Dai-2-bu 37 (1987) 49-55 [Chem. Abstr. 107 (1987) 236662w].
19. [15] Y. Ahmad, M.S. Habib, M. Iqbal, M.I. Qureshi, B.B. Ziauddin, Quinoxaline derivatives, VII. The mechanism of the formation of 6-chloro-1,2,3,4,2′,3′-hexahydro-4,1′-dimethyl-3,2′-dioxoquinoxaline-2-spiro-3′-indole from a quinoxaline N-oxide derivative by nucleophilic chlorination, Bull. Chem. Soc. Jpn. 38 (1965) 1659-1663.
20. [16] A.H. Gowenlock, G.T. Newbold, F.S. Spring, Syntheses of 2-monosubstituted and 2,3-disubstituted quinoxalines, J. Chem. Soc. (1945) 622-625.
21. [17] R. Van Dusen, H.P. Schultz, Quinoxaline studies, IX. The preparation of 3-methyl-6-and -7-bromo-2-quinoxalinols, J. Org. Chem. 21 (1956) 1326-1327.
22. [18] A. Katoh, T. Yoshida, J. Ohkanda, T. Nishio, Structural analysis of N-(ω-phenylalkyl) substituted quinoxalin-2(1H)-ones and -thiones, Heterocycles 44 (1997) 357-366.
23. [19] M. Jackman, S. Sternhell, Application of Nuclear Magnetic Resonance Spectroscopy in Organic Chemistry, Pergamon, Oxford, 1969, pp. 204-208.
24. [20] G.C. Finger, F.H. Reed, J.L. Finnerty, Aromatic fluorine compounds, V. 1,3,5-Trifluoro benzene, J. Am. Chem. Soc. 73 (1951) 153-155.
25. [21] H.J. Braun, Fluoronitrophenylenediamine derivatives; their preparation and use in hair dyes, Ger. Offen. DE 3 707 273 (1988) [Chem. Abstr. 110 (1989) 28915r].
26. [21] H.J. Braun, Fluoronitrophenylenediamine derivatives; their preparation and use in hair dyes, Ger. Offen. DE 3 707 273 (1988) [Chem. Abstr. 110 (1989) 28915r].
27. [22] Wella AG, Preparation of 3-mesylaminoanilines as coupling agents for oxidative hair dyes, Ger. Offen. DE 3 521 995 (1987) [Chem. Abstr. 111 (1989) 180459y].
28. [22] Wella AG, Preparation of 3-mesylaminoanilines as coupling agents for oxidative hair dyes, Ger. Offen. DE 3 521 995 (1987) [Chem. Abstr. 111 (1989) 180459y].
29. [23] M.M. El-Abadelah, S.S. Sabri, M.H. Abu Zarga, R.J. Abdel-Jalil, Substituted benzimidazoles, Part I. Synthesis and properties of some 2-ary1-5-ftuoro-6-(4-methyl-1-piperazinyl)-1H-benzimidazoles, Heterocycles 41 (1995) 2713-2728.
30. [24] M.M. El-Abadelah, M.Z. Nazer, N.S. El-Abadla, H. Meier, 6-Fluoro7-(1-piperazinyl)quinoxaline 1,4-dioxides, Part I. 2-(N-2-Hydroxy-alkylcarbamoyl) derivatives, Heterocycles 41 (1995) 2203-2219.
31. [25] M.R. Boyd, Status of the NCI Preclinical Antitumor Drug Discovery Screen, Princ. Pract. Oncol. 3 (10) (1989) 1-12.
32. [26] O.W. Weislow, R. Kiser, D. Fine, J. Bader, R.H. Shoemaker, M.R. Boyd, New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity, J. Natl. Cancer Inst. 81 (1989) 577-586.